Hemostasis Products Market 2024 – By Size, Share, Forecast And Trends Analysis Report 2033

The Hemostasis Products Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Hemostasis Products Market:
https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

According to The Business Research Company’s Hemostasis Products Global Market Report 2024, The hemostasis products market size has grown strongly in recent years. It will grow from $1.59 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%.  The  growth in the historic period can be attributed to rise in surgical procedures, growing aging population, increasing incidence of hemophilia, expanding healthcare infrastructure, rising awareness about blood clotting disorders.

The hemostasis products market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%.  The growth in the forecast period can be attributed to rising demand for minimally invasive surgeries, global increase in trauma cases, expansion of hemostasis applications in chronic diseases, shift towards ambulatory surgical centers, personalized medicine and biomarker research. Major trends in the forecast period include technological innovations in hemostasis, advancements in hemostatic technologies, rising preference for minimally invasive procedures, growing incidence of chronic diseases, focus on biodegradable hemostatic agents.

The increase in the prevalence of blood disorders is expected to propel the growth of the hemostasis products market going forward. Blood disorders, also known as hematologic disorders, refer to a group of medical conditions that affect the composition, function, and behavior of blood and its components. Hemostasis products are used in various blood disorders to help regulate the clotting and bleeding processes in the body. It can address both excessive bleeding (hemorrhage) and excessive clotting (thrombosis) that can occur in different blood disorders. For instance, in June 2021, according to the Leukemia Foundation, an Australia-based non-profit organization, there were approximately 110,000 people living with blood disorders in Australia in 2021. By 2035, it is expected that this number will increase to more than 275,000 cases due to the rise in the incidence of blood cancer and blood disorders in Australia. Therefore, an increase in the prevalence of blood disorders is driving the growth of the hemostasis products market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13244&type=smp

The hemostasis products market covered in this report is segmented –

1) By Product: Topical Hemostasis Product, Infusible Hemostasis Product, Advanced Hemostasis Product

2) By Application: Trauma, Surgery, Hemophilia, Myocardial Infarction, Other Applications

3) By End User: Hospitals, Clinics, Other End Users

Top Major Players
Pfizer Inc.
Abbott Laboratorie
Thermo Fisher Scientific Inc.
Medtronic PLC
Johnson And Johnson Pvt. Ltd.

Major companies operating in the hemostasis products market are developing innovative drugs such as the Nexpowder endoscopic hemostasis system and getting approval to have a full range of active and passive hemostatic products for bleeding control. An endoscopic hemostasis system is a medical device and technique used to control bleeding in the gastrointestinal (GI) tract during endoscopic procedures. For instance, in September 2022, Medtronic plc, a US-based medical device company received clearance from the U.S. Food and Drug Administration for the Nexpowder Endoscopic Hemostasis System for the treatment of nonvariceal upper GI bleeding. This innovative hemostatic product is designed to be used in conjunction with endoscopy. Moreover, it has the potential to make a significant impact on the treatment of nonvariceal upper GI bleeding as it is easy to use, effective, and well-tolerated.

The hemostasis products market report table of contents includes:
1. Executive Summary
2. Hemostasis Products Market Characteristics
3. Hemostasis Products Market Trends And Strategies
4. Hemostasis Products Market – Macro Economic Scenario
5. Global Hemostasis Products Market Size and Growth
……………………..
32. Global Hemostasis Products Market Competitive Benchmarking
33. Global Hemostasis Products Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Hemostasis Products Market
35. Hemostasis Products Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model